Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome

Abstract

The diagnosis of acute respiratory distress syndrome (ARDS) traditionally requires calculation of the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (PaO₂/FiO₂) using arterial blood, which can be costly and is not possible in many resource-limited settings. By contrast, pulse oximetry is continuously available, accurate, inexpensive, and non-invasive. Pulse oximetry-based indices, such as the ratio of pulse-oximetric oxygen saturation to FiO₂ (SpO₂/FiO₂), have been validated in clinical studies for the diagnosis and risk stratification of patients with ARDS. Limitations of the SpO₂/FiO₂ ratio include reduced accuracy in poor perfusion states or above oxygen saturations of 97%, and the potential for reduced accuracy in patients with darker skin pigmentation. Application of pulse oximetry to the diagnosis and management of ARDS, including formal adoption of the SpO₂/FiO₂ ratio as an alternative to PaO₂/FiO₂ to meet the diagnostic criterion for hypoxaemia in ARDS, could facilitate increased and earlier recognition of ARDS worldwide to advance both clinical practice and research.